1025 / 1601
ESTRO IG and Adaptive
Course Parikh Budapest 2018
SCRT + Chemo Trial
Toxicity
•
Pre-operative: G3 GI 9%, G3 Heme 14%, G4 Heme 13%
•
Late toxicity: 21 ≥ G3 events, 13 RT-related
75% had sphincter-preserving surgeries
4% R1 resections
25% ypCR
Conclusion: Well-tolerated with good treatment response, but need longer
follow-up to assess disease outcomes